Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases

Ming-Shi Chang (Inventor)

Research output: Patent

Abstract

This invention features an antibody specifically binding to human IL-20 (e.g., mAb 7E and a equivalent thereof) and its use in treating an IL-20 associated inflammatory disease, such as atherosclerosis, RA, psoriasis, psoriatic arthritis, bacteria-induced gastric ulcer, and acute renal failure.
Original languageEnglish
Patent number7611705
Publication statusPublished - 2008 Dec 18

Fingerprint

Psoriatic Arthritis
Antibodies
Stomach Ulcer
Psoriasis
Acute Kidney Injury
Atherosclerosis
Bacteria
interleukin 20

Cite this

@misc{7a543759591d48a59173f244903982af,
title = "Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases",
abstract = "This invention features an antibody specifically binding to human IL-20 (e.g., mAb 7E and a equivalent thereof) and its use in treating an IL-20 associated inflammatory disease, such as atherosclerosis, RA, psoriasis, psoriatic arthritis, bacteria-induced gastric ulcer, and acute renal failure.",
author = "Ming-Shi Chang",
year = "2008",
month = "12",
day = "18",
language = "English",
type = "Patent",
note = "7611705",

}

TY - PAT

T1 - Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases

AU - Chang, Ming-Shi

PY - 2008/12/18

Y1 - 2008/12/18

N2 - This invention features an antibody specifically binding to human IL-20 (e.g., mAb 7E and a equivalent thereof) and its use in treating an IL-20 associated inflammatory disease, such as atherosclerosis, RA, psoriasis, psoriatic arthritis, bacteria-induced gastric ulcer, and acute renal failure.

AB - This invention features an antibody specifically binding to human IL-20 (e.g., mAb 7E and a equivalent thereof) and its use in treating an IL-20 associated inflammatory disease, such as atherosclerosis, RA, psoriasis, psoriatic arthritis, bacteria-induced gastric ulcer, and acute renal failure.

M3 - Patent

M1 - 7611705

ER -